China Universal Asset Management Co., Ltd. Autolus Therapeutics PLC Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 35,157 shares of AUTL stock, worth $48,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,157
Previous 40,273
12.7%
Holding current value
$48,868
Previous $91,000
37.36%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding AUTL
# of Institutions
103Shares Held
150MCall Options Held
24.6KPut Options Held
41.9K-
Mak Capital One LLC New York, NY26MShares$36.2 Million6.54% of portfolio
-
Blackstone Inc New York, NY20.5MShares$28.5 Million0.15% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$23.1 Million97.83% of portfolio
-
Armistice Capital, LLC New York, NY15.6MShares$21.7 Million0.39% of portfolio
-
Tfg Asset Management Gp LTD Grand Cayman, E99.5MShares$13.2 Million3.44% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $126M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...